Assignee
WIGEN BIOMEDICINE TECH SHANGHAI CO LTD
CN·14 granted patents·13 pending applications·4 citations·filing 2018–2024
Top patents by PatentIndex Score
27 records- 0178US11021457B2Class of isoindolone-imide ring-1,3-dione-2-ene compounds, composition and use thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2018·Granted Jun 1, 2021·2 cites·9 claims
- 0277US11529321B2Use of aminomethylenecyclohexane-1,3-dione compoundWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2018·Granted Dec 20, 2022·1 cites·2 claims
- 0371US12122774B2Compounds as MYT1 inhibitorsWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2024·Granted Oct 22, 2024·0 cites·16 claims
- 0471US11319303B2Compound used as autophagy regulator, and preparation method therefor and uses thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2018·Granted May 3, 2022·1 cites·6 claims
- 0559US12577250B21,2,4-triazolone derivative as DHODH inhibitor, and preparation method therefor and use thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2022·Granted Mar 17, 2026·0 cites·6 claims
- 0658US2025154134A1Compound as fak inhibitor and use thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 0758US2024317741A1Naphthyridine derivative as atr inhibitor and method for preparing sameWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0854US2024208978A1Idh mutant inhibitor and use thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 0954US2024182482A1Fused cyclic compound as wee-1 inhibitor, preparation method therefor and use thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1053US12559505B2IDH mutant inhibitor and use thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2021·Granted Feb 24, 2026·0 cites·4 claims
- 1153US12351582B2Aurora kinase inhibitors and uses thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2021·Granted Jul 8, 2025·0 cites·6 claims
- 1253US11993598B2Compounds for inhibiting EGFR kinase, preparation methods and uses thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2021·Granted May 28, 2024·0 cites·3 claims
- 1353US2024336624A1Parp inhibitor containing piperazine structure, preparation method therefor and pharmaceutical use thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 1453US2025197382A1Kif18a inhibitorWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 1553US2023416270A1Novel camptothecin derivative, composition comprising same and use thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 1652US12391692B2Spiro ring-containing quinazoline compoundWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2021·Granted Aug 19, 2025·0 cites·7 claims
- 1751US12522607B2Substituted pyrazolo[3,4-d]pyrimidines as wee-1 inhibitorsWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2021·Granted Jan 13, 2026·0 cites·9 claims
- 1851US12479843B2Spiro ring-containing quinazoline compoundsWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2020·Granted Nov 25, 2025·0 cites·18 claims
- 1951US12275726B2Aurora kinase inhibitors and use thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2020·Granted Apr 15, 2025·0 cites·7 claims
- 2051US2025042904A1Compounds used as src inhibitorsWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 2150US12497397B2Pyrrole compounds useful as antifungalsWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2020·Granted Dec 16, 2025·0 cites·10 claims
- 2249US11286247B2Acryloyl-containing nuclear transport regulators and uses thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2020·Granted Mar 29, 2022·0 cites·11 claims
- 2349US2024158369A1Pyrimidine compound as wee-1 inhibitorWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 2449US2023130909A1Hpk1 inhibitor, preparation method therefor and use thereofWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2021·Application pending·0 cites
- 2549US2024182447A1Fused ring compound as wee-1 inhibitorWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2022·Application pending·0 cites
- 2646US2026035382A1Compounds as sumo activating enzyme inhibitorsWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2023·Application pending·0 cites
- 2740US2020069609A1Method for covalent bond modifying mammalian atg8 homologueWIGEN BIOMEDICINE TECH SHANGHAI CO LTD·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when WIGEN BIOMEDICINE TECH SHANGHAI CO LTD files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →